Mergers and Acquisitions

Bayer to Acquire KaNDy Therapeutics for up to $875 Million

August 12, 2020

The company will use the acquisition to further its drug development pipeline in women’s healthcare.

Dealing a Blow to Biopharma

August 02, 2020

COVID-19’s impact on the global economy is dealing a blow to merger and acquisition activity in the biopharma industry.

LGM Pharma Acquires Nexgen

July 29, 2020

The acquisition gives LGM access to Nexgen’s manufacturing and warehouse distribution facilities and a pilot plant.

ABITEC Acquires Larodan for Lipid Product Expansion

July 09, 2020

Through the acquisition, the companies plan to build a global science-based organization that uses product innovation to enhance ABITEC’s scientific and commercial interests.

Vetter Expands Fill/Finish Capacity with Acquisition of New Site in Austria

July 08, 2020

The acquisition will give the CDMO additional clinical filling options in Europe, which is expected to come online in 2021.

Piramal Pharma Solutions Acquires Solid Oral Dosage Drug Product Manufacturing Facility

June 22, 2020

The facility has dedicated manufacturing and packaging for oral solid dosage forms, liquids, creams, and ointments.

Novavax Acquires Praha Vaccines, Expands Large-Scale Vaccine Manufacturing Capacity

June 01, 2020

The acquisition gives Novovax an annual operating capacity of more that one billion doses of COVID-19 vaccine antigen.

Merck Acquires Themis, Advances SARS-CoV-2 Vaccine Program

May 28, 2020

Merck will use Themis’s vector platform to develop a vaccine to prevent COVID-19.

Merck Announces Acquisition, Collaborations for Developing COVID-19 Vaccines and Therapies

May 28, 2020

Merck will acquire Themis Bioscience and collaborate with IAVI and Ridgeback Bio on COVID-19 vaccines and therapies.

Catalent to Acquire Japanese Clinical Packaging Facility

May 26, 2020

The 60,000-ft2 facility will work in conjunction with the company’s Kakegawa, Japan, clinical supply facility to serve local and global biotech and pharmaceutical companies.